Toronto (June 3, 2019) — Borden Ladner Gervais (BLG) has released the sixth edition of Life Sciences Legal Trends in Canada (LifeSigns). This report showcases key insights from our Life Sciences Group, highlighting market trends and developments.

BLG's LifeSigns report covers notable trends in the areas of Intellectual Property, Regulatory Affairs, Privacy and Cybersecurity, as well as Capital Markets, and includes articles on topics such as amendments to the Canadian Patent Act, the import and export of cannabis, the modernization of food regulations and the introduction of third party rights in Canada.

"With the number of new legislative changes and amendments affecting the industry that have been introduced, our professionals have combined their insights to create this concise examination of areas that will most strongly impact clients. It's a need-to-know for industry leaders," said Mark Vickers, national leader of BLG's Life Sciences Group.

BLG's multi-disciplinary Life Sciences Group advises entrepreneurs and investors involved in the commercialization of life sciences technologies, as well as domestic and international clients with products for purchase, including drugs, medical devices, natural health products, biomaterials, ag-biotech products as well as companies with energy/environmental applications. Our practice extends from bench top to boardroom, providing strategic advice to clients across the sector.